Bayer Articles
Stock Commentary - Europe - week to July 30, 2007
6 August 2007
S-P's 2nd-quarter 2007 EPS doubles to $0.34
30 July 2007
Premier extends deal with Bayer for contrast media
30 July 2007
Stock Commentary - Europe - week to July 16, 2007
23 July 2007
Pegylation of Factor VIII improves function
23 July 2007
Yaz approved in the Netherlands
16 July 2007
Stock Commentary - Europe - week to July 9, 2007
16 July 2007
UK's ABPI "admonishes" Bayer, GSK and Roche
16 July 2007
New 2,000 IU vial size for Bayer's Kogenate
9 July 2007
COMP adopts positive opinion on 10 new drugs
9 July 2007
Bayer makes $726M selling chemical unit to Dow
9 July 2007
Bayer drops out of alfimeprase accord
9 July 2007
Bayer/Onyx submit US sNDA for Nexavar in HCC
2 July 2007
Stock Commentary - Europe - week to June 18, 2007
25 June 2007
Bayer submits EMEA MAA for Nexavar in HCC
25 June 2007
ZymoGenetics licenses rThrombin to Bayer
25 June 2007
GW reports 2.6% loss reduction to L6.7M
25 June 2007
S-P/Bayer's Zetia launched in Japan
18 June 2007
Bayer to showcase health care business to analysts
18 June 2007
Japan's Chuikyo adds 13 NCEs to NHI list
18 June 2007
Stock Commentary - Europe - week to June 4, 2007
11 June 2007
Nexavar extends survival in liver cancer
11 June 2007
Sinclair's Atopiclair launched in Europe
11 June 2007
Stock Commentary - Europe - week to May 28, 2007
4 June 2007
Stock Commentary - Europe - week to May 21, 2007
28 May 2007
Bayer to consolidate Japanese operations
21 May 2007
Stock Commentary - Europe - week to May 14, 2007
21 May 2007
GSK returns rights to Futura Medical's ED gel
21 May 2007
Stock Commentary - Europe - week to May 7, 2007
14 May 2007
Bayer and Intendis to promote Yaz for acne
14 May 2007
Bayer to join wound-care market
14 May 2007
Strong Ph II data on Genzyme/Bayer's MS drug
14 May 2007
FDA OKs Barr's generic Nimotop
7 May 2007
Bayer examines Glucobay in CV prevention
30 April 2007
Bayer/S-P's Zetia approved in Japan
23 April 2007
Stock Commentary - Europe - week to April 16, 2007
23 April 2007
NHI price cuts hit Bayer Yakuhin results
23 April 2007
Biogen's Avonex: most cost-effective INF-beta
23 April 2007
Stock Commentary - Europe - week to April 9
16 April 2007
Bayer sues over Teva's US generic Avelox
16 April 2007
Genzyme/Bayer file for Campath label expansion
16 April 2007
Betaferon NAbs not key to poor clinical response
16 April 2007
Bayer reorganizes US healthcare business
16 April 2007
Stock Commentary - Europe - week to April 2
9 April 2007
Adalat demonstrates additional CV benefits
9 April 2007
Stock Commentary - Europe - week to March 26
2 April 2007
Bayer/Regeneron VEGF trap cuts retina thickness
2 April 2007
Strong data on Bayer's Testogel and Nebido
2 April 2007
Bayer and Novartis in MS drug deal
2 April 2007
Cannabinoid market forecast at over $700 million
26 March 2007
Bayer Schering reports strong data on Levitra at EAU
26 March 2007
Stock Commentary - Europe - week to Mar 19
26 March 2007
Stock Commentary - Europe - week to March 12, 2007
26 March 2007
Bayer's 2006 income climbs 5.4%
19 March 2007
$8.9M neglected tropical disease research boost
19 March 2007
$8.9M neglected tropical disease research boost
19 March 2007
Poor 2006 for French drugmakers goes on
12 March 2007
Bayer to save 700M euros pa via job cuts
12 March 2007
Stock Commentary - Europe - week to Feb 26, 2007
5 March 2007
BIO survey rebuts Part D price negotiation plan
5 March 2007
Bayer buys Pharmonyx' distribution network
26 February 2007
Stock Commentary - Europe - week to Feb 19, 2007
26 February 2007
Favrille signs FavID accord with Berlex
19 February 2007
Law suit filed against Nuvelo
19 February 2007
UPDATE: Bayer/Onyx' Nexavar achieves excellent safety and efficacy results in Ph III HCC trial
19 February 2007
Nexavar sees very strong Ph III data in HCC
19 February 2007
Bayer's Kogenate gets EU OK for use in surgery
19 February 2007
Bayer Schering's Mirena cleared in Japan
12 February 2007
Stock Commentary - Europe - week to Feb 5, 2007
12 February 2007
Bayer's Trasylol linked to CABG mortality risk
12 February 2007
CSL and Bayer extend Helixate deal
12 February 2007
Walter Wenninger joins Santaris board
5 February 2007
Stock Commentary - Europe - week to Jan 29, 2007
5 February 2007
Yaz cleared for acne by the FDA
5 February 2007
Bayer's oral Fludara gets MHLW approval
5 February 2007
Bayer stops non-CABG Trasylol studies
5 February 2007
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
